| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.48B | +11.5% |
| Cost of Revenue | $1.96B | +16.4% |
| Gross Profit | $1.52B | +5.7% |
| R&D Expense | $878.5M | +11.4% |
| SG&A Expense | $403.2M | +17.0% |
| Operating Income | -$792.4M | -49.3% |
| Pre-tax Income | -$699.4M | -42.1% |
| Income Tax | $10.1M | +77.1% |
| Net Income | -$709.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.03B | +3.3% |
| Accounts Receivable | $816.3M | +7.3% |
| Inventory | $92.1M | -13.7% |
| Current Assets | $3.07B | +3.6% |
| Total Assets | $4.26B | -3.4% |
| Current Liabilities | $1.28B | +17.7% |
| Total Liabilities | $1.94B | +9.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $255.9M | +2069.2% |
| Capital Expenditures | $82.6M | -48.9% |
| Investing Cash Flow | -$92.6M | +54.1% |
| Financing Cash Flow | -$61.2M | -832.8% |
| Free Cash Flow | $173.2M | +215.6% |
| -42.5% |
| EPS (Basic) | -$5.01 | -38.4% |
| EPS (Diluted) | -$5.01 | -38.4% |
| Stockholders' Equity |
| $2.33B |
| -12.1% |